ID26650A - Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik - Google Patents

Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik

Info

Publication number
ID26650A
ID26650A IDW20002368A ID20002368A ID26650A ID 26650 A ID26650 A ID 26650A ID W20002368 A IDW20002368 A ID W20002368A ID 20002368 A ID20002368 A ID 20002368A ID 26650 A ID26650 A ID 26650A
Authority
ID
Indonesia
Prior art keywords
alginic acid
levosimendants
compositions containing
stable compositions
levosimendan
Prior art date
Application number
IDW20002368A
Other languages
English (en)
Indonesian (id)
Inventor
Ilkka Larma
Maarit Harjula
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of ID26650A publication Critical patent/ID26650A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IDW20002368A 1998-04-23 1999-04-23 Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik ID26650A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia

Publications (1)

Publication Number Publication Date
ID26650A true ID26650A (id) 2001-01-25

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002368A ID26650A (id) 1998-04-23 1999-04-23 Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik

Country Status (33)

Country Link
US (1) US6531458B1 (cs)
EP (1) EP1079834B1 (cs)
JP (1) JP4475809B2 (cs)
KR (1) KR100590622B1 (cs)
CN (1) CN1165309C (cs)
AT (1) ATE231395T1 (cs)
AU (1) AU756338B2 (cs)
BG (1) BG64766B1 (cs)
BR (1) BR9909867A (cs)
CA (1) CA2329232C (cs)
CZ (1) CZ290911B6 (cs)
DE (1) DE69905034T2 (cs)
DK (1) DK1079834T3 (cs)
EA (1) EA002428B1 (cs)
EE (1) EE04143B1 (cs)
ES (1) ES2191426T3 (cs)
FI (1) FI980902A (cs)
GE (1) GEP20032942B (cs)
HK (1) HK1031998A1 (cs)
HR (1) HRP20000703B1 (cs)
HU (1) HUP0105446A3 (cs)
ID (1) ID26650A (cs)
IL (2) IL138950A0 (cs)
MX (1) MXPA00010368A (cs)
NO (1) NO318575B1 (cs)
NZ (1) NZ507455A (cs)
PL (1) PL192274B1 (cs)
PT (1) PT1079834E (cs)
RS (1) RS49955B (cs)
SK (1) SK284600B6 (cs)
TR (1) TR200003101T2 (cs)
WO (1) WO1999055337A1 (cs)
ZA (1) ZA200005630B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
JPWO2002064120A1 (ja) * 2001-02-13 2004-06-10 大正製薬株式会社 内服ゲル製剤
US20080194567A1 (en) * 2005-03-14 2008-08-14 Piero Pollesello Combination Treatment for Enhancing Diuresis
PL3370693T3 (pl) * 2015-11-06 2020-07-13 Carinopharm Gmbh Ulepszone preparaty lewosimendanu do podawania dożylnego w postaci roztworów do wlewów lub wstrzykiwań i koncentratu do wlewów
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NZ203684A (en) * 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
CN1165309C (zh) 2004-09-08
RS49955B (sr) 2008-09-29
ATE231395T1 (de) 2003-02-15
HUP0105446A2 (hu) 2002-07-29
FI980902A (fi) 1999-10-24
WO1999055337A1 (en) 1999-11-04
SK284600B6 (sk) 2005-07-01
NO20005312L (no) 2000-11-21
EP1079834A1 (en) 2001-03-07
KR20010072577A (ko) 2001-07-31
BG64766B1 (bg) 2006-03-31
FI980902A0 (fi) 1998-04-23
TR200003101T2 (tr) 2001-01-22
HUP0105446A3 (en) 2002-09-30
JP4475809B2 (ja) 2010-06-09
EA002428B1 (ru) 2002-04-25
DE69905034D1 (de) 2003-02-27
IL138950A (en) 2006-08-20
AU756338B2 (en) 2003-01-09
HK1031998A1 (en) 2001-07-06
BR9909867A (pt) 2000-12-19
HRP20000703A2 (en) 2001-04-30
CZ290911B6 (cs) 2002-11-13
NZ507455A (en) 2002-02-01
PL192274B1 (pl) 2006-09-29
YU64000A (sh) 2002-12-10
HRP20000703B1 (en) 2009-11-30
DK1079834T3 (da) 2003-04-07
MXPA00010368A (es) 2002-07-02
CZ20003779A3 (en) 2001-05-16
CA2329232A1 (en) 1999-11-04
CN1298303A (zh) 2001-06-06
EP1079834B1 (en) 2003-01-22
EA200001097A1 (ru) 2001-04-23
DE69905034T2 (de) 2003-09-04
PT1079834E (pt) 2003-04-30
NO20005312D0 (no) 2000-10-20
EE200000616A (et) 2002-06-17
BG104958A (en) 2001-07-31
ES2191426T3 (es) 2003-09-01
GEP20032942B (en) 2003-04-25
JP2002512964A (ja) 2002-05-08
US6531458B1 (en) 2003-03-11
SK15552000A3 (sk) 2001-05-10
NO318575B1 (no) 2005-04-11
IL138950A0 (en) 2001-11-25
PL343722A1 (en) 2001-09-10
CA2329232C (en) 2007-10-30
ZA200005630B (en) 2002-01-14
AU3524899A (en) 1999-11-16
KR100590622B1 (ko) 2006-06-19
EE04143B1 (et) 2003-10-15

Similar Documents

Publication Publication Date Title
FR2714830B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
ATE289332T1 (de) Silikongel enthaltend salizylsäure
BR9810450A (pt) Derivados de ácido barbitúrico com atividade antimetastática e antitumor
BRPI9917007B8 (pt) azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso
ATE292460T1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
FI972628A (fi) Uudet sulfonamidit
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
CA2224528A1 (fr) Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
CA2238465A1 (fr) Composes triaromatiques, compositions les contenant et utilisations
AU2001283353A1 (en) Compositions containing hypoglycemically active stilbenoids
FR2826270B1 (fr) Lingette et ses utilisations dans le domaine cosmetique
NO20061138L (no) Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
GB9928820D0 (en) Stable high glycerol liquids comprising sulfosuccinic acid monoesters
ID26650A (id) Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik
CA2305933A1 (fr) Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
HUP9801593A2 (hu) Benazeprilt vagy benazeprilátot és valzartánt tartalmazó kombinált gyógyszerkészítmények és azok alkalmazása
DE122005000032I2 (de) Verwendung von 2-(2-Nitro-4-Trifluormethylbenzoyl)-1,3-Cyclohexandion zur Behandlung von Tyrosin{miesowie Pharmazeutische Zusammensetzungen
CA2291650A1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
ATE90354T1 (de) Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden.
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
ATE389014T1 (de) Phosphorylierte glyoxalase i und deren verwendung
UA30826A (uk) Спосіб лікування хейліту